HCM
NVO

Herndon Capital Management’s Novo Nordisk NVO Stock Holding History

Herndon Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2K Hold
102
– – ﹤0.01% 195
2017
Q1 		$2K Hold
102
– – ﹤0.01% 186
2016
Q4 		$2K Buy
+102
New +$1.85K ﹤0.01% 211

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Herndon Capital Management's NVO Position: Q2 2017 in Review

Herndon Capital Management held its Novo Nordisk (NVO) position steady in Q2 2017 at 102 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #195.

Herndon Capital Management first reported a position in NVO in Q4 2016 and has held it in 3 quarters since. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • Herndon Capital Management held 102 shares of Novo Nordisk worth $2K as of Q2 2017.
  • Herndon Capital Management left its Novo Nordisk share count unchanged in Q2 2017.
  • Novo Nordisk made up ﹤0.01% of Herndon Capital Management's portfolio in Q2 2017, its #195 holding.
  • Herndon Capital Management first reported a position in Novo Nordisk in Q4 2016 and has held it in 3 quarters since.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.